EnClear Therapies Announces Seed Funding and Senior R&D Appointment
— $2 million in seed funding raised to advance development —
— Kevin Kalish joins EnClear as Vice-President of Research and
Development —
CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear
Therapies, a biotechnol…